{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:28:38Z","timestamp":1791494918813,"version":"4.3.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Educ"],"DOI":"10.1186\/s12909-025-06871-y","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:23:48Z","timestamp":1741173828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Further education in psychedelic-assisted therapy \u2013 experiences from Switzerland"],"prefix":"10.1186","volume":"25","author":[{"given":"H.D.","family":"Aicher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"6871_CR1","doi-asserted-by":"publisher","unstructured":"Aicher & Mueller, H. D. & M. J., Dornbierer, D. A., Suay, D., Elsner, C., Wicki, I., Meling, D., Caflisch, L., Hempe, A., Steinhart, C., Mueller, J., Von Rotz, R., Kleim, B., & Scheidegger, M. (2024). Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: A controlled trial in healthy subjects. Frontiers in Psychiatry, 14, 1302559.\u00a0https:\/\/doi.org\/10.3389\/fpsyt.2023.1302559.","DOI":"10.3389\/fpsyt.2023.1302559"},{"issue":"2","key":"6871_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00278-024-00711-y","volume":"69","author":"HD Aicher","year":"2024","unstructured":"Aicher HD, Schmid Y, Gasser P. Psychedelika-assistierte Psychotherapie: Erfahrungen mit der beschr\u00e4nkten medizinischen Anwendung von LSD, MDMA und Psilocybin in der Schweiz. Die Psychotherapie. 2024;69(2):98\u2013106. https:\/\/doi.org\/10.1007\/s00278-024-00711-y.","journal-title":"Die Psychotherapie"},{"key":"6871_CR3","doi-asserted-by":"publisher","unstructured":"Aicher, H. D., Wolff, M., & Herwig, U. (2024). Psychedelic therapy \u2013 refining the claim of a paradigm shift. International Review of Psychiatry, 1\u20138. https:\/\/doi.org\/10.1080\/09540261.2024.2410853.","DOI":"10.1080\/09540261.2024.2410853"},{"key":"6871_CR4","doi-asserted-by":"publisher","unstructured":"Aicher, H., & Gasser, P. (2024). Treatment Recommendations for Psychedelic-assisted Therapy. Swiss Archives of Neurology, Psychiatry and Psychotherapy.https:\/\/doi.org\/10.4414\/sanp.2024.1488043038.","DOI":"10.4414\/sanp.2024.1488043038"},{"issue":"2","key":"6871_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/acps.13249","volume":"143","author":"KAA Andersen","year":"2021","unstructured":"Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D. Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies. Acta Psychiatr Scand. 2021;143(2):101\u201318. https:\/\/doi.org\/10.1111\/acps.13249.","journal-title":"Acta Psychiatr Scand"},{"key":"6871_CR6","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1177\/0269881116678781","volume":"30","author":"FS Barrett","year":"2016","unstructured":"Barrett FS, Bradstreet MP, Leoutsakos JMS, Johnson MW, Griffiths RR. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. J Psychopharmacol. 2016;30:1279\u201395. https:\/\/doi.org\/10.1177\/0269881116678781.","journal-title":"J Psychopharmacol"},{"key":"6871_CR7","doi-asserted-by":"publisher","unstructured":"Barrett, F. S., & Griffiths, R. R. (2017). Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates (pp. 1\u201338). Springer, Berlin, Heidelberg. https:\/\/doi.org\/10.1007\/7854_2017_474.","DOI":"10.1007\/7854_2017_474"},{"key":"6871_CR8","doi-asserted-by":"publisher","first-page":"1232459","DOI":"10.3389\/fnins.2023.1232459","volume":"17","author":"T Buchborn","year":"2023","unstructured":"Buchborn T, Kettner HS, K\u00e4rtner L, Meinhardt MW. The ego in psychedelic drug action \u2013 ego defenses, ego boundaries, and the therapeutic role of regression. Front Neurosci. 2023;17:1232459. https:\/\/doi.org\/10.3389\/fnins.2023.1232459.","journal-title":"Front Neurosci"},{"key":"6871_CR9","doi-asserted-by":"publisher","unstructured":"Bukar, A., Abdullah, A., Opara, J. A., M, A., & Hassan, A. (2019). Catharsis as a therapy: An overview on health and human development. J Physical Health Sports Med, 31\u201335. https:\/\/doi.org\/10.36811\/jphsm.2019.110007.","DOI":"10.36811\/jphsm.2019.110007"},{"issue":"15","key":"6871_CR10","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1056\/nejmoa2032994","volume":"384","author":"R Carhart-Harris","year":"2021","unstructured":"Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R, Martell J, Blemings A, Erritzoe D, Nutt DJ. Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med. 2021;384(15):1402\u201311. https:\/\/doi.org\/10.1056\/nejmoa2032994.","journal-title":"N Engl J Med"},{"key":"6871_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00213-017-4701-y","volume":"235","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris RL, Erritzoe D, Haijen E, Kaelen M, Watts R. Psychedelics and connectedness. Psychopharmacology. 2018;235:547\u201350. https:\/\/doi.org\/10.1007\/s00213-017-4701-y.","journal-title":"Psychopharmacology"},{"key":"6871_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3714-z","author":"RL Carhart-Harris","year":"2015","unstructured":"Carhart-Harris RL, Kaelen M, Whalley MG, Bolstridge M, Feilding A, Nutt DJ. LSD enhances suggestibility in healthy volunteers. Psychopharmacology. 2015. https:\/\/doi.org\/10.1007\/s00213-014-3714-z.","journal-title":"Psychopharmacology"},{"issue":"4","key":"6871_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0269881120967878","volume":"35","author":"AK Davis","year":"2021","unstructured":"Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR. Development of the Psychological Insight Questionnaire among a sample of people who have consumed psitlocybin or LSD. J Psychopharmacol. 2021;35(4):437\u201346. https:\/\/doi.org\/10.1177\/0269881120967878.","journal-title":"J Psychopharmacol"},{"issue":"3","key":"6871_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/13642537.2013.811278","volume":"15","author":"J Edwards","year":"2013","unstructured":"Edwards J. Examining the role and functions of self-development in healthcare therapy trainings: A review of the literature with a modest proposal for the use of learning agreements. Eur J Psychotherapy Counselling. 2013;15(3):214\u201332. https:\/\/doi.org\/10.1080\/13642537.2013.811278.","journal-title":"Eur J Psychotherapy Counselling"},{"issue":"5","key":"6871_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1080\/03069885.2017.1334110","volume":"46","author":"J Edwards","year":"2018","unstructured":"Edwards J. The extant rationale for mandated therapy during psychotherapy and counselling training: A critical interpretive synthesis. Br J Guid Couns. 2018;46(5):515\u201330. https:\/\/doi.org\/10.1080\/03069885.2017.1334110.","journal-title":"Br J Guid Couns"},{"key":"6871_CR16","doi-asserted-by":"publisher","unstructured":"Emmerich, N., & Humphries, B. (2023). Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist\u2019s Training? Cambridge Quarterly of Healthcare Ethics, 1\u201310. https:\/\/doi.org\/10.1017\/S0963180123000099.","DOI":"10.1017\/S0963180123000099"},{"key":"6871_CR17","first-page":"59","volume":"147","author":"P Gasser","year":"1996","unstructured":"Gasser P. Die psycholytische Therapie in der Schweiz von 1988\u20131993. Schweiz Arch Neurol Psychiatr. 1996;147:59\u201365.","journal-title":"Schweiz Arch Neurol Psychiatr"},{"key":"6871_CR18","doi-asserted-by":"publisher","unstructured":"Gasser, P. (2021). Psychedelic Group Therapy.https:\/\/doi.org\/10.1007\/7854_2021_268.","DOI":"10.1007\/7854_2021_268"},{"issue":"7","key":"6871_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","volume":"202","author":"P Gasser","year":"2014","unstructured":"Gasser P, Holstein D, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, Brenneisen R. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. J Nerv Ment Dis. 2014;202(7):513\u201320. https:\/\/doi.org\/10.1097\/NMD.0000000000000113.","journal-title":"J Nerv Ment Dis"},{"key":"6871_CR20","doi-asserted-by":"publisher","unstructured":"Gita Vaid. (2023). Psychoanalysis and Psychedelic Psychotherapy \u2013 A New Modern Synthesis? In Paolo Azzone (Ed.), The Wounds of Our Mother Psychoanalysis (p. Ch. 4). IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.109095.","DOI":"10.5772\/intechopen.109095"},{"issue":"18","key":"6871_CR21","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","volume":"387","author":"GM Goodwin","year":"2022","unstructured":"Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, Debattista C, Dunlop BW, Eisen K, Feifel D, Malievskaia E. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. New England J Med. 2022;387(18):1637\u201348. https:\/\/doi.org\/10.1056\/NEJMoa2206443.","journal-title":"New England J Med"},{"key":"6871_CR22","doi-asserted-by":"publisher","unstructured":"Goodwin, G. M., Malievskaia, E., Fonzo, G. A., & Nemeroff, C. B. (2023). Must Psilocybin Always \u201cAssist Psychotherapy\u201d? American Journal of Psychiatry, appi.ajp.20221043. https:\/\/doi.org\/10.1176\/appi.ajp.20221043.","DOI":"10.1176\/appi.ajp.20221043"},{"key":"6871_CR23","unstructured":"Government of Canada. (2023). Notice to stakeholders: Requests to the Special Access Program (SAP) involving psychedelic-assisted psychotherapy. https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/announcements\/requests-special-access-program-psychedelic-assisted-psychotherapy.html."},{"key":"6871_CR24","unstructured":"Grawe, K. (2004). Psychological Therapy. Hogrefe & Huber."},{"issue":"3","key":"6871_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","volume":"187","author":"RR Griffiths","year":"2006","unstructured":"Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. 2006;187(3):268\u201383. https:\/\/doi.org\/10.1007\/s00213-006-0457-5.","journal-title":"Psychopharmacology"},{"key":"6871_CR26","first-page":"677","volume":"68","author":"L Grinspoon","year":"2001","unstructured":"Grinspoon L, Doblin R. Psychedelics as Catalysts of Insight-Oriented. Psychotherapy. 2001;68:677\u201395.","journal-title":"Psychotherapy"},{"key":"6871_CR27","doi-asserted-by":"publisher","unstructured":"Guss, J., Krause, R., & Sloshower, J. (2020). The Yale Manual for Psilocybin-Assisted Therapy of Depression (using Acceptance and Commitment Therapy as a Therapeutic Frame). https:\/\/doi.org\/10.31234\/osf.io\/u6v9y.","DOI":"10.31234\/osf.io\/u6v9y"},{"issue":"7969","key":"6871_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/d41586-023-02093-8","volume":"619","author":"R Haridy","year":"2023","unstructured":"Haridy R. Australia to prescribe MDMA and psilocybin for PTSD and depression in world first. Nature. 2023;619(7969):227\u20138. https:\/\/doi.org\/10.1038\/d41586-023-02093-8.","journal-title":"Nature"},{"issue":"3","key":"6871_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","volume":"93","author":"F Holze","year":"2023","unstructured":"Holze F, Gasser P, M\u00fcller F, Dolder PC, Liechti ME. Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind Placebo-Controlled Phase II Study. Biological Psychiatry. 2023;93(3):215\u201323. https:\/\/doi.org\/10.1016\/j.biopsych.2022.08.025.","journal-title":"Biological Psychiatry"},{"issue":"3","key":"6871_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1192\/bjp.2024.99","volume":"225","author":"F Holze","year":"2024","unstructured":"Holze F, Gasser P, M\u00fcller F, Strebel M, Liechti ME. LSD-assisted therapy in patients with anxiety: Open-label prospective 12-month follow-up. Br J Psychiatry. 2024;225(3):362\u201370. https:\/\/doi.org\/10.1192\/bjp.2024.99.","journal-title":"Br J Psychiatry"},{"issue":"6","key":"6871_CR31","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0269881108093587","volume":"22","author":"M Johnson","year":"2008","unstructured":"Johnson M, Richards W, Griffiths R. Human hallucinogen research: Guidelines for safety. J Psychopharmacol. 2008;22(6):603\u201320. https:\/\/doi.org\/10.1177\/0269881108093587.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"6871_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1176\/appi.ajp.2019.19010035","volume":"29","author":"JN Kirby","year":"2022","unstructured":"Kirby JN, Tellegen CL, Steindl SR, Glennon RA, Jim\u00e9nez JH, Bouso JC, Barker SA, Gasser P, Kirchner K, Passie T, Barker SA, Mcilhenny EH, Strassman RJ, Sanches RF, de Lima Osorio F, Dos Santos RG, Macedo LR, Maia-De-Oliveira JP, Wichert-Ana L, Ara\u00fajo DB. Psychedelics and Psychedelic-Assisted Psychotherapy. Psychopharmacology. 2022;29(1):1\u201310. https:\/\/doi.org\/10.1176\/appi.ajp.2019.19010035.","journal-title":"Psychopharmacology"},{"key":"6871_CR33","doi-asserted-by":"publisher","first-page":"917199","DOI":"10.3389\/fpsyt.2022.917199","volume":"13","author":"K Ko","year":"2022","unstructured":"Ko K, Knight G, Rucker JJ, Cleare AJ. Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review. Front Psych. 2022;13:917199. https:\/\/doi.org\/10.3389\/fpsyt.2022.917199.","journal-title":"Front Psych"},{"issue":"1","key":"6871_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s40429-021-00401-8","volume":"9","author":"M Koslowski","year":"2021","unstructured":"Koslowski M, Johnson MW, Gr\u00fcnder G, Betzler F. Novel Treatment Approaches for Substance Use Disorders: Therapeutic Use of Psychedelics and the Role of Psychotherapy. Curr Addict Rep. 2021;9(1):48\u201358. https:\/\/doi.org\/10.1007\/s40429-021-00401-8.","journal-title":"Curr Addict Rep"},{"issue":"1","key":"6871_CR35","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5964\/ejcop.v6i1.116","volume":"6","author":"N Kumari","year":"2017","unstructured":"Kumari N. Personal therapy for therapists: Reflections on past and current research from an autoethnographic perspective. Eur J Counselling Psychology. 2017;6(1):83\u201395. https:\/\/doi.org\/10.5964\/ejcop.v6i1.116.","journal-title":"Eur J Counselling Psychology"},{"key":"6871_CR36","doi-asserted-by":"publisher","first-page":"104122","DOI":"10.1016\/j.cognition.2019.104122","volume":"196","author":"RE Laukkonen","year":"2020","unstructured":"Laukkonen RE, Kaveladze BT, Tangen JM, Schooler JW. The dark side of Eureka: Artificially induced Aha moments make facts feel true. Cognition. 2020;196:104122. https:\/\/doi.org\/10.1016\/j.cognition.2019.104122.","journal-title":"Cognition"},{"key":"6871_CR37","doi-asserted-by":"publisher","DOI":"10.1556\/2054.2024.00373","author":"J Lichtenstein","year":"2024","unstructured":"Lichtenstein J, Hoeh NR. Psychedelics and psychoanalysis: The journey from talking cure to transformation. J Psych Stud. 2024. https:\/\/doi.org\/10.1556\/2054.2024.00373.","journal-title":"J Psych Stud"},{"key":"6871_CR38","unstructured":"Lu, D. (2023). Australian psychiatrists can now prescribe MDMA and psilocybin: Who can access them and how do they work? The Guardian. https:\/\/www.theguardian.com\/australia-news\/2023\/jul\/01\/australian-psychiatrists-can-now-prescribe-mdma-and-psilocybin-who-can-access-them-and-how-do-they-work."},{"issue":"6","key":"6871_CR39","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jamapsychiatry.2024.0184","volume":"81","author":"M Marks","year":"2024","unstructured":"Marks M, Brendel RW, Shachar C, Cohen IG. Essentials of Informed Consent to Psychedelic Medicine. JAMA Psychiat. 2024;81(6):611\u20137. https:\/\/doi.org\/10.1001\/jamapsychiatry.2024.0184.","journal-title":"JAMA Psychiat"},{"issue":"1","key":"6871_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s44271-024-00120-6","volume":"2","author":"HT McGovern","year":"2024","unstructured":"McGovern HT, Grimmer HJ, Doss MK, Hutchinson BT, Timmermann C, Lyon A, Corlett PR, Laukkonen RE. An Integrated theory of false insights and beliefs under psychedelics. Communications Psychology. 2024;2(1):69. https:\/\/doi.org\/10.1038\/s44271-024-00120-6.","journal-title":"Communications Psychology"},{"key":"6871_CR41","doi-asserted-by":"publisher","unstructured":"Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot\u2019alora G, M., Garas, W., Paleos, C., Gorman, I., Nicholas, C., Mithoefer, M., Carlin, S., Poulter, B., Mithoefer, A., Quevedo, S., Wells, G., Klaire, S. S., van der Kolk, B., \u2026 Doblin, R. (2021). MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27(6), 1025\u20131033. https:\/\/doi.org\/10.1038\/s41591-021-01336-3.","DOI":"10.1038\/s41591-021-01336-3"},{"key":"6871_CR42","unstructured":"Mithoefer, M. C. (2015). A Manual for MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder."},{"issue":"1","key":"6871_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/19012276.2020.1762713","volume":"73","author":"FD Moe","year":"2021","unstructured":"Moe FD, Thimm J. Personal therapy and the personal therapist. Nordic Psychology. 2021;73(1):3\u201328. https:\/\/doi.org\/10.1080\/19012276.2020.1762713.","journal-title":"Nordic Psychology"},{"issue":"4","key":"6871_CR44","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/13642530903444803","volume":"11","author":"NP Moller","year":"2009","unstructured":"Moller NP, Timms J, Alilovic K. Risky business or safety net? Trainee perceptions of personal therapy: A qualitative thematic analysis. Eur J Psychotherapy Counsell. 2009;11(4):369\u201384. https:\/\/doi.org\/10.1080\/13642530903444803.","journal-title":"Eur J Psychotherapy Counsell"},{"issue":"4","key":"6871_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1055\/a-1312-7297","volume":"54","author":"S Nayak","year":"2021","unstructured":"Nayak S, Johnson MW. Psychedelics and Psychotherapy. Pharmacopsychiatry. 2021;54(4):167\u201375. https:\/\/doi.org\/10.1055\/a-1312-7297.","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"6871_CR46","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1177\/00221678211021204","volume":"64","author":"EM Nielson","year":"2024","unstructured":"Nielson EM. Psychedelics as a Training Experience for Psychedelic Therapists: Drawing on History to Inform Current Practice. J Humanist Psychol. 2024;64(4):618\u201334. https:\/\/doi.org\/10.1177\/00221678211021204.","journal-title":"J Humanist Psychol"},{"issue":"2","key":"6871_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1556\/2054.2018.009","volume":"2","author":"EM Nielson","year":"2018","unstructured":"Nielson EM, Guss J. The influence of therapists\u2019 first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training. Journal of Psychedelic Studies. 2018;2(2):64\u201373. https:\/\/doi.org\/10.1556\/2054.2018.009.","journal-title":"Journal of Psychedelic Studies"},{"key":"6871_CR48","doi-asserted-by":"crossref","unstructured":"Orlinsky, D. E., & Howard, K. I. (1967). The Good Therapy Hour \u2013 Experiential Correlates of Patients\u2019 and Therapists\u2019 Evaluations of Therapy Sessions. Arch Gen Psychiat, 16.","DOI":"10.1001\/archpsyc.1967.01730230105013"},{"issue":"4","key":"6871_CR49","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1017\/S0033291718001356","volume":"49","author":"F Palhano-Fontes","year":"2019","unstructured":"Palhano-Fontes F, Barreto D, Onias H, Andrade KC, Novaes MM, Pessoa JA, Mota-Rolim SA, Os\u00f3rio FL, Sanches R, Dos Santos RG, T\u00f3foli LF, De Oliveira Silveira G, Yonamine M, Riba J, Santos FR, Silva-Junior AA, Alchieri JC, Galv\u00e3o-Coelho NL, Lob\u00e3o-Soares B, Ara\u00fajo DB. Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: A randomized placebo-controlled trial. Psychol Med. 2019;49(4):655\u201363. https:\/\/doi.org\/10.1017\/S0033291718001356.","journal-title":"Psychol Med"},{"key":"6871_CR50","doi-asserted-by":"publisher","unstructured":"Passie, T., Guss, J., & Kr\u00e4henmann, R. (2022). Lower-dose psycholytic therapy \u2013 A neglected approach. Frontiers in Psychiatry, 13. https:\/\/doi.org\/10.3389\/fpsyt.2022.1020505.","DOI":"10.3389\/fpsyt.2022.1020505"},{"issue":"5","key":"6871_CR51","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1177\/0022167817711304","volume":"57","author":"J Phelps","year":"2017","unstructured":"Phelps J. Developing Guidelines and Competencies for the Training of Psychedelic Therapists. J Humanist Psychol. 2017;57(5):450\u201387. https:\/\/doi.org\/10.1177\/0022167817711304.","journal-title":"J Humanist Psychol"},{"issue":"7","key":"6871_CR52","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1177\/02698811231155117","volume":"37","author":"P Ponomarenko","year":"2023","unstructured":"Ponomarenko P, Seragnoli F, Calder A, Oehen P, Hasler G. Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors. J Psychopharmacol. 2023;37(7):660\u201378. https:\/\/doi.org\/10.1177\/02698811231155117.","journal-title":"J Psychopharmacol"},{"key":"6871_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2016.12.030","author":"KH Preller","year":"2017","unstructured":"Preller KH, Herdener M, Pokorny T, Planzer A, Kraehenmann R, St\u00e4mpfli P, Liechti ME, Seifritz E, Vollenweider FX. The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation. Curr Biol. 2017. https:\/\/doi.org\/10.1016\/j.cub.2016.12.030.","journal-title":"Curr Biol"},{"key":"6871_CR54","doi-asserted-by":"publisher","unstructured":"Richards, W. (2015). Sacred Knowledge: Psychedelics and Religious Experiences. Columbia University Press.\u00a0https:\/\/doi.org\/10.7312\/columbia\/9780231174060.001.0001.","DOI":"10.7312\/columbia\/9780231174060.001.0001"},{"key":"6871_CR55","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1037\/h0059730","volume":"13","author":"CR Rogers","year":"1949","unstructured":"Rogers CR. The attitude and orientation of the counselor in client-centered therapy. J Consult Psychol. 1949;13:82\u201394.","journal-title":"J Consult Psychol"},{"key":"6871_CR56","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","volume":"30","author":"S Ross","year":"2016","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. J Psychopharmacol. 2016;30:1165\u201380. https:\/\/doi.org\/10.1177\/0269881116675512.","journal-title":"J Psychopharmacol"},{"key":"6871_CR57","doi-asserted-by":"publisher","unstructured":"Schmid, Y., Enzler, F., Gasser, P., Grouzmann, E., Preller, K. H., Vollenweider, F. X., Brenneisen, R., M\u00fcller, F., Borgwardt, S., & Liechti, M. E. (2015). Acute effects of lysergic acid diethylamide in healthy subjects. Biological Psychiatry, 78(8). https:\/\/doi.org\/10.1016\/j.biopsych.2014.11.015.","DOI":"10.1016\/j.biopsych.2014.11.015"},{"key":"6871_CR58","doi-asserted-by":"publisher","unstructured":"Strau\u00df, B., & Taeger, D. (2021). Untersuchungen zur \u201eWirkung\u201c von Selbsterfahrung inder Psychotherapieausbildung \u2013 Ein systematischesReview. PPmP - Psychotherapie Psychosomatik Medizinische Psychologie, 71(12), 489\u2013498. https:\/\/doi.org\/10.1055\/a-1499-8115.","DOI":"10.1055\/a-1499-8115"},{"issue":"2","key":"6871_CR59","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1023\/A:1010382104323","volume":"29","author":"AL Strozier","year":"2001","unstructured":"Strozier AL, Stacey L. The Relevance of Personal Therapy in the Education of MSW Students. Clin Soc Work J. 2001;29(2):181\u201395. https:\/\/doi.org\/10.1023\/A:1010382104323.","journal-title":"Clin Soc Work J"},{"issue":"5","key":"6871_CR60","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1177\/13634615221082796","volume":"59","author":"C Timmermann","year":"2022","unstructured":"Timmermann C, Watts R, Dupuis D. Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations. Transcult Psychiatry. 2022;59(5):691\u2013704. https:\/\/doi.org\/10.1177\/13634615221082796.","journal-title":"Transcult Psychiatry"},{"key":"6871_CR61","doi-asserted-by":"publisher","unstructured":"Vaid, G. (2023). Psychoanalysis and Psychedelic Psychotherapy \u2013 A New Modern Synthesis? In P. Azzone (Ed.), The Wounds of Our Mother Psychoanalysis\u2014New Models for Psychoanalysis in Crisis. IntechOpen. https:\/\/doi.org\/10.5772\/intechopen.109095.","DOI":"10.5772\/intechopen.109095"},{"key":"6871_CR62","doi-asserted-by":"publisher","unstructured":"Villiger, D. (2024). Personal psychedelic experience of psychedelic therapists during training: Should it be required, optional, or prohibited? International Review of Psychiatry, 1\u201310. https:\/\/doi.org\/10.1080\/09540261.2024.2357669.","DOI":"10.1080\/09540261.2024.2357669"},{"key":"6871_CR63","doi-asserted-by":"publisher","first-page":"101809","DOI":"10.1016\/j.eclinm.2022.101809","volume":"56","author":"R von Rotz","year":"2023","unstructured":"von Rotz R, Schindowski EM, Jungwirth J, Schuldt A, Rieser NM, Zahoranszky K, Seifritz E, Nowak A, Nowak P, J\u00e4ncke L, Preller KH, Vollenweider FX. Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. eClinicalMedicine. 2023;56:101809. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101809.","journal-title":"eClinicalMedicine"},{"key":"6871_CR64","doi-asserted-by":"publisher","unstructured":"Wampold, B. E., & Imel, Z. E. (2015). The great psychotherapy debate: The evidence for what makes psychotherapy work: Second edition.\u00a0https:\/\/doi.org\/10.4324\/9780203582015.","DOI":"10.4324\/9780203582015"},{"key":"6871_CR65","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/0022167817709585","volume":"57","author":"R Watts","year":"2017","unstructured":"Watts R, Day C, Krzanowski J, Nutt D, Carhart-Harris R. Patients\u2019 accounts of increased \u201cconnectedness\u201d and \u201cacceptance\u201d after psilocybin for treatment-resistant depression. J Humanist Psychol. 2017;57:520\u201364. https:\/\/doi.org\/10.1177\/0022167817709585.","journal-title":"J Humanist Psychol"},{"issue":"5","key":"6871_CR66","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/02698811241249698","volume":"38","author":"M Wolff","year":"2024","unstructured":"Wolff M, Evens R, Mertens LJ, Schmidt C, Beck J, Rutrecht H, Cherniak AD, Gr\u00fcnder G, Jungaberle H. Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ). J Psychopharmacol. 2024;38(5):432\u201357. https:\/\/doi.org\/10.1177\/02698811241249698.","journal-title":"J Psychopharmacol"},{"key":"6871_CR67","doi-asserted-by":"publisher","first-page":"873279","DOI":"10.3389\/fpsyg.2022.873279","volume":"13","author":"DB Yaden","year":"2022","unstructured":"Yaden DB, Earp D, Graziosi M, Friedman-Wheeler D, Luoma JB, Johnson MW. Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default. Front Psychol. 2022;13:873279. https:\/\/doi.org\/10.3389\/fpsyg.2022.873279.","journal-title":"Front Psychol"}],"container-title":["BMC Medical Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12909-025-06871-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12909-025-06871-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12909-025-06871-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T11:23:54Z","timestamp":1741173834000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmededuc.biomedcentral.com\/articles\/10.1186\/s12909-025-06871-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6871"],"URL":"https:\/\/doi.org\/10.1186\/s12909-025-06871-y","relation":{},"ISSN":["1472-6920"],"issn-type":[{"value":"1472-6920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Peter Gasser, past president of the Swiss Medical Association for Psychedelic Therapy, S\u00c4PT, paid consultant for Mind Medicine Inc, Compass Pathways LLC, Reconnect Foundation. Felix M\u00fcller is co-president of the Swiss Medical Association for Psychedelic Therapy. He has no other conflicts of interest to declare. Helena D. Aicher, part of the S\u00c4PT training committee, involved in psychedelic research and therapy, scientific advisor for several foundations, was paid consultant for MindMedicine Inc.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"341"}}